Rao Harsha L

Torbey Julien, Weinreb Robert N, Rao Harsha L, Mansouri Kaweh

Five 18-hour IOP measurements characterize 24-hour rhythm, showing early morning peaks. This supports strategic home monitoring for comprehensive IOP fluctuation assessment, improving glaucoma management beyond clinic visits.

Torbey Julien, Nassri Amir, Rao Harsha L, Mansouri Kaweh

AS-OCT showed MINIject implantation effectively lowered IOP and medication use, with gradual reduction in suprachoroidal fluid over 6 months, confirming device function and stability.

Rao Harsha L, Dasari Srilakshmi, Puttaiah Narendra K, Pradhan Zia S, Moghimi Sasan, Mansouri Kaweh et al.

In mild-moderate PACG, younger age and higher peak IOP, but not baseline OMAG, predicted faster RNFL loss, suggesting OMAG's limited role in predicting structural progression.

Rao Divya Parthasarathy, Shroff Sujani, Savoy Florian M, S Shruthi, Hsu Chao-Kai, Negiloni Kalpa et al.

This study found an offline smartphone-based AI system accurately detected referable glaucoma (93.7% sensitivity, 85.6% specificity), outperforming specialists on images. This offers a promising, affordable screening tool for undetected glaucoma.

Torbey Julien, Paillard Archibald, Rao Harsha L, Gillman Kevin, Bravetti Giorgio E, Mermoud André et al.

XEN 45 gel stent implantation for open-angle glaucoma showed safe, sustained IOP and medication reduction over 5 years, offering a valuable long-term treatment option for patients.

Szurman Peter, Gillmann Kevin, Seuthe Anna-Maria, Dick H Burkhard, Hoffmann Esther M, Mermoud Andre et al.

The EYEMATE-SC suprachoroidal sensor was studied for continuous IOP monitoring. It proved safe, well-tolerated, and accurately measured IOP for 12 months, offering a promising tool for glaucoma management.

Micheletti Eleonora, Moghimi Sasan, Nishida Takashi, El-Nimri Nevin, Mahmoudinezhad Golnoush, Kamalipour Alireza et al.

This study found that worsening choroidal microvasculature dropout is significantly linked to faster retinal nerve fiber layer thinning in glaucoma, suggesting MvD progression indicates disease severity.

Noury Erfan, Mannil Suria S, Chang Robert T, Ran An Ran, Cheung Carol Y, Thapa Suman S et al.

A 3D deep learning model accurately detected glaucoma from OCT scans across diverse populations, highlighting the lamina cribrosa as a key diagnostic area, which could improve early detection.

Pradhan Zia S, Dixit Shivani, Krishna Lekshmi, Shetty Reshma, Tejwani Sushma, Rao Harsha L et al.

Studying NOTCH signaling in pseudoexfoliation, researchers found it upregulated in PXF, but not PXG. This suggests NOTCH activation in the lens may protect against glaucoma development.

Gillmann Kevin, Meduri Enrico, Paillard Archibald, Bravetti Giorgio E, Rao Harsha L, Mermoud André et al.

This study found bilateral deep sclerectomy outcomes are linked; success in the first eye significantly increases the odds of success in the second eye by 6-fold.

Rao Harsha L, Dasari Srilakshmi, Puttaiah Narendra K, Pradhan Zia S, Moghimi Sasan, Mansouri Kaweh et al.

This study found that lower baseline peripapillary OMAG (perfusion/vessel density) was associated with faster ganglion cell loss in mild-moderate glaucoma, suggesting OMAG may predict disease progression.

Rao Harsha L, Srinivasan Thanemozhi, Pradhan Zia S, Sreenivasaiah Shruthi, Rao Dhanaraj A S, Puttaiah Narendra K et al.

Rao Harsha L, Dasari Srilakshmi, Puttaiah Narendra K, Pradhan Zia S, Moghimi Sasan, Mansouri Kaweh et al.

OMAG's baseline peripapillary perfusion and vessel density predicted faster retinal nerve fiber layer loss in POAG, indicating its utility for assessing glaucoma progression risk.

Pradhan Zia S, Sircar Tushar, Agrawal Harshit, Rao Harsha L, Bopardikar Ajit, Devi Sathi et al.

This study found a smartphone-based perimeter (GearVision) had good agreement with standard HFA and was preferred by patients, suggesting its potential for portable or home glaucoma monitoring.

Rao Harsha L, Srinivasan Thanemozhi, Pradhan Zia S, Sreenivasaiah Shruthi, Rao Dhanaraj A S, Puttaiah Narendra K et al.

In PACG, lower retinal vessel density measured by OCTA is linked to faster visual field decline, suggesting OCTA can help identify patients at higher risk of progression.

Gillmann Kevin, Rao Harsha L, Mansouri Kaweh

Laser trabeculoplasty temporarily increased macular vascular density at two months, but this effect was not sustained at six months, despite continued IOP reduction.

Ramyashri S, Rao Harsha L, Jonnadula Ganesh Babu, Addepalli Uday K, Choudhari Nikhil, Senthil Sirisha et al.

This study found age, sex, axial length, disc area, and OCT signal strength significantly influence retinal nerve fiber layer and ganglion cell thickness in normal eyes. These factors are crucial for accurate glaucoma diagnosis.

Senthil Sirisha, Burugupally Keerthi, Rout Umashankar, Rao Harsha L, Krishnamurthy Rashmi, Badakere Swathi et al.

Intravenous dexmedetomidine significantly lowered intraocular pressure (33% in 15 minutes) in glaucoma patients pre-surgery, suggesting its potential as a safe, rapid IOP-reducing agent.

Gillmann Kevin, Bravetti Giorgio Enrico, Rao Harsha L, Mermoud André, Mansouri Kaweh

XEN gel stent implantation significantly lowered IOP and medication use at 3 years for glaucoma, despite needing frequent revisions. Identifying high-risk patients preoperatively is crucial.

Lavanya Raghavan, Riyazuddin Mohammed, Dasari Srilakshmi, Puttaiah Narendra K, Venugopal Jayasree P, Pradhan Zia S et al.

SITA Faster visual fields were significantly quicker than SITA Standard, showing comparable diagnostic parameters and good agreement. This makes SITA Faster a viable, efficient option for glaucoma diagnosis and monitoring.

Mansouri Kaweh, Rao Harsha L, Weinreb Robert N

Using an implanted sensor, this study found glaucoma patients have moderate short-term and high long-term IOP variability. Single IOP measurements are insufficient; continuous monitoring is crucial for managing glaucoma.

Gillmann Kevin, Bravetti Giorgio E, Rao Harsha L, Mermoud André, Mansouri Kaweh

This study found bilateral XEN stent outcomes are linked: success in the first eye predicts 16-fold higher success in the second eye, guiding patient counseling and surgical planning.

Elahi Sina, Rao Harsha L, Dumitru Alina, Mansouri Kaweh

This study found SLT success in the fellow eye strongly predicts treatment outcome in the current eye, aiding patient selection for this glaucoma therapy.

Elahi Sina, Rao Harsha L, Paillard Archibald, Mansouri Kaweh

This study compared PSLT and SLT for glaucoma/OHT, finding no significant difference in long-term safety or efficacy. Both procedures effectively lowered IOP, with higher baseline IOP predicting better success.

Bravetti Giorgio Enrico, Mansouri Kaweh, Gillmann Kevin, Rao Harsha L, Mermoud André

XEN-augmented Baerveldt implants moderately reduced IOP in refractory glaucoma, but 41.5% required reoperation within a year, indicating limited long-term success despite initial IOP reduction.